Circulation: Arrhythmia and Electrophysiology. 2008;1:317-320
doi: 10.1161/CIRCEP.108.785865
Images and Case Reports in Arrhythmia and Electrophysiology |
Cardiac Myotonic Dystrophy Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy in a Young Sudden Cardiac Death Victim
Alex Hoerby Christensen, MD
;
Henning Bundgaard, MD, DMSc
;
Marianne Schwartz, MSc, PhD
;
Steen Holger Hansen, MD
and
Jesper Hastrup Svendsen, MD, DMSc
From the Departments of Cardiology (A.H.C., H.B., J.H.S.), Clinical Genetics (M.S.), Forensic Medicine (S.H.H.), Rigshospitalet; The Danish National Research Foundation Centre for Cardiac Arrhythmia (A.H.C., J.H.S.), Copenhagen; and Surgery and Medicine, Faculty of Health Sciences, University of Copenhagen (J.H.S.), Copenhagen, Denmark.
Correspondence to Alex Hoerby Christensen, MD, Department of Cardiology 2142, The Heart Centre, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. E-mail alexhc{at}dadlnet.dk
An 11-year-old girl sitting in the kitchen suddenly complained of dizziness. Seconds later, she collapsed and had cardiac arrest. Cardiopulmonary resuscitation was initiated immediately but was unsuccessful, despite prolonged efforts. The girl was previously healthy and had never experienced any cardiac or muscular symptoms.
At autopsy, the gross examination was normal. The heart weighed 230 g; the chamber sizes, wall thicknesses, and myocardial appearance were normal. Microscopic examination of the right ventricular myocardium showed marked fibrofatty replacement (Figures 1 and 2
). No replacements were found in the left ventricular myocardium or in the skeletal musculature. On this basis, it was concluded that the cause of death was arrhythmogenic right ventricular cardiomyopathy (ARVC).
The patients relatives (
Figure 3) were referred for clinical
and genetic counseling because of presumed ARVC-related death
in the family. At the interview, it was revealed that an aunt
had a child with severe myotonic dystrophy type 1 (DM1). Careful
examination revealed that the patients brother and father had
vague muscular symptoms and that the father previously had cataract
surgery. It was hypothesized that the cause of death was unrecognized
cardiac DM1 instead of ARVC. Genetic testing of the patient,
her brother, and her father revealed a high number of CTG repeats
in the dystrophia myotonica protein kinase (
DMPK) gene, diagnostic
of DM1. Screening of the ARVC-related genes plakophilin-2 (
PKP2)
and desmoglein-2 (
DSG2) were negative. The likely cause of death
was revised to cardiac DM1. Because of conduction defects, the
brother and father were fitted with prophylactic implantable
cardioverter-defibrillators.

View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3. Pedigree. Individuals with myotonic dystrophy type 1 are marked in gray and the proband is marked with an arrow. The top numbers refer to the approximate number of CTG repeats in the 3' untranslated region of the DMPK gene, and the bottom numbers refer to the age (in years) at the time of diagnosis. Unaffected individuals have between 5 and 35 copies.
|
|
The histopathologic hallmark of ARVC is fibrofatty replacement.
It is a common cause of sudden cardiac death in the young.
1 The diagnosis, which is based on a set of criteria, is often
challenging. Differential diagnoses include right ventricular
outflow tract tachycardia, cardiac sarcoidosis, myocarditis,
Uhl anomaly, idiopathic dilated cardiomyopathy, and other inherited
cardiac arrhythmia syndromes. An implantable cardioverter-defibrillator
is often recommended for treatment of ARVC.
Approximately 30% of patients with DM1 experience cardiac involvement at some stage. The risk of cardiac involvement may correlate with the number of CTG repeats.2 The most common feature is conduction defects, but ventricular tachyarrhythmias and ventricular function impairment are also seen. Electroanatomic mapping of the right cardiac chambers in patients with DM1 have shown widespread alterations, consistent with a generalized myocardial affection.3 Endomyocardial biopsies from patients with DM1 may show a variety of nonspecific findings, including fibrosis, fatty infiltrations, hypertrophy, and inflammation.4
To exclude cardiac DM1 as a frequent cause of misdiagnosis of ARVC, we screened our cohort of 63 unrelated patients with ARVC and ARVC-like diseases for an expanded number of CTG repeats. All had a normal number of CTG repeats. As no confirmatory test exists for ARVC, it cannot completely be ruled out that the patient had both DM1 and ARVC. We think that all the characteristic findings of the patient and her family can be explained by DM1, and the statistical probability of coincidence of ARVC and DM1 is extremely low. We conclude that cardiac DM1 may mimic ARVC, and this should be considered in patient handling and in family screening.
 |
Sources of Funding
|
|---|
This work was supported by the Danish Arrhythmia Research Foundation
Centre for Cardiac Arrhythmia, the Danish Cardiovascular Research
Academy, and the Research Foundation at the Heart Centre at
Rigshospitalet.
Disclosures
None.
 |
References
|
|---|
1. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis?
Circulation. 1996; 94: 983–991.
[Abstract/Free Full Text]2. Groh WJ, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002; 13: 444–448.[CrossRef][Medline]
3. Russo AD, Pelargonio G, Parisi Q, Santamaria M, Messano L, Sanna T, Casella M, Martino GD, Ponti RD, Pace M, Giglio V. Widespread electroanatomic alternations of right cardiac chambers in patients with myotonic dystrophy type 1. J Cardiovasc Electrophysiol. 2006; 17: 34–40.[CrossRef][Medline]
4. Nguyen HH, Wolfe JT, Holmes DR, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol. 1988; 11: 662–671.[Abstract]
Related Article
-
Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Implantable Cardioverter Defibrillator Implantation Guidelines Based Solely on Left Ventricular Ejection Fraction Do Not Apply to Adults With Congenital Heart Disease
- John K. Triedman
Circ Arrhythmia Electrophysiol 2008 1: 307-316.
[Extract]
[Full Text]
[PDF]